News and media
Read our latest news, see departmental media and ministerial releases, and learn how you can have your say.
Departmental media enquiries
Contact for members of the media
Campaign launched to encourage parents and carers to get their kids vaccinated on time for the best protection.
The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Pfizer COVID-19 vaccine in children aged 5 to 11 years.
A statement from Australia's Chief Medical Officer, Professor Paul Kelly, about Australian children returning from overseas.
Dr Lucas de Toca, COVID-19 Primary Care Response First Assistant Secretary, answers the top three questions you’ve been asking on our social accounts.
Find out more information about COVID-19 vaccinations for people 12 years and older.
World Breastfeeding Week (1-7 August 2021) reminds us that we all have a role in supporting breastfeeding. Partners, carers, families, communities, workplaces, and governments can all help infants have a healthy start in life.
An updated statement from the Australian Health Protection Principal Committee (AHPPC) on on minimising the potential risk of COVID-19 transmission in schools.
A statement from the Australian Health Protection Principal Committee (AHPPC) about risk management for boarding schools and school-based residential colleges.
The Australian Government has committed $33 million towards research to combat high-mortality and low-survivability cancers and diseases, improve paediatric acute care using genomic medicine, and address the ethical, legal and social issues related to genomics in health care.
The Australian Government, together with the Minderoo Foundation, will provide an additional $67 million to ensure every child in Australia with cancer will have access to life-saving treatment.
Delivering the world’s best mental health system — stigma-free and focused on prevention, starting with children under 12 — is the major focus of the Australian Government’s Long Term National Health Plan, outlined today.
The Australian Government is continuing to step up its commitment with the Pacific, pledging an additional $19 million to boost health care across the region.
The Australian Government is expanding access to a critically important medicine on the Pharmaceutical Benefits Scheme (PBS) that will help infants living with Cystic Fibrosis and save their families up to $300,000 per year.
The number of Australian children who are fully immunised continues to increase to record levels with new data showing more parents are getting the message to protect their children with life-saving vaccines.
AusVaxSafety is a national system for monitoring vaccine safety in Australia. The report shows how parents and carers responded to the SMS about their child's health a few days after their vaccination at each schedule point in the National Immunisation Program (NIP) in Australia in 2016-17.
The Australian Government will invest $3 million under the Medical Research Future Fund to advance stem cell research projects for kids.
Recent data released by the Australian Immunisation Register shows coverage rates amongst Australian children continue to improve.
The ‘Get the facts about immunisation’ campaign has launched to encourage Australian parents and carers to get their kids vaccinated.
From early 2018, young Australians have free access to the new human papillomavirus (HPV) vaccine, Gardasil®9 that protects against more types of HPV infection.
Coverage rates amongst Australian children continue to improve with 5 year old children having the highest coverage rates in history. 94% of Australian 5 year olds and over 96% of Aboriginal and Torres Strait Islander 5 year olds are now fully vaccinated.
The Australian Government is extending childhood immunisation arrangements for family assistance payments to increase immunisation rates of children residing in Australia.
An additional $6 incentive payment will be made to vaccination providers and GPs who follow up and vaccinate children.
A pertussis (whooping cough) booster has been added to the NIP for children at 18 months of age.
Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
The Pertussis Chapter, 4.12, of the 10th Edition of the Australian Immunisation Handbook has been updated and includes two changes to recommendations in the administration of pertussis-containing vaccine.
Health portfolio news and events
For news and events from our portfolio agencies, go to Our portfolio for links to their websites.